Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts ...

Lenacapavir has demonstrated enormous potential as a new HIV prevention tool with a 100 per cent efficacy rate and zero ...

Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...

Steve Drayton, a man living with HIV and a three-time cancer survivor, has dedicated the last 30 years of his life to ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

Updated at 3:38 p.m. ET on May 31, 2025 Solving HIV vaccination—a puzzle that scientists have been tackling for decades without success—could be like cracking the code to a safe.

There is no HIV vaccine approved by the US Food and Drug Administration. However, recently two HIV vaccine trials were conducted in the US and Africa. A study, based on those trials and published in ...